Physician preferences for non-metastatic castration-resistant prostate cancer treatment

Overview of attention for article published in BMC Urology, June 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 33 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

Therapeutic Options for Nonmetastatic Castration-Resistant Prostate Cancer

Cancer Therapy Advisor, 29 Oct 2021

Moffitt Cancer Center Key Takeaways Nonmetastatic castration-resistant prostate cancer (M0 CRPC) is characterized by a rising…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.